What is the Size of Cell Therapy Technologies Market?
The Cell Therapy Technologies market size is forecast to increase by USD 5.92 billion and is estimated to grow at a CAGR of 19.7% between 2023 and 2028. The market is witnessing significant growth, driven by the increasing investment in premarket approval-exempt therapies and investigational therapies. The therapeutic benefits of cell therapy, including the potential for personalized medicine and improved clinical safety, efficacy, and genetic engineering, are attracting substantial interest from both industry and regulatory bodies. However, high costs related to cell therapy technologies pose a significant challenge, necessitating continuous innovation and optimization. Infusions and related technologies are key areas of focus to enhance the efficacy and safety of cell therapies, while ensuring regulatory compliance. The market is expected to continue its growth trajectory, driven by these trends and challenges.
Request Free Cell Therapy Technologies Market Sample
Market Segment
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
- Technology
- Somatic cell technologies
- Gene modification techniques
- Genome editing technologies
- Others
- End-user
- Biopharmaceuticals and biotechnology companies
- CROs and CMOs
- Research institute and cell banks
- Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
Which is the Largest Segment Driving Market Growth?
The somatic cell technologies segment is estimated to witness significant growth during the forecast period. The market encompasses various segments, with somatic cell technologies holding a substantial position. Somatic cell therapies utilize viable cells extracted from the patient's body, which are then purified, cultivated, and transformed into specific cellular products. These cells, without undergoing additional technological enhancements, are reintroduced into the patient's body for therapeutic applications.
Get a glance at the market share of various regions Download the PDF Sample
The somatic cell technologies segment was the largest segment and was valued at USD 860 million in 2018. The techniques employed for purifying, cultivating, and transforming these cells can be intricate. However, the innovation factor in this technology category is relatively low due to the long-standing use of many somatic cell therapies. Skin stem cells, for instance, are often used in burn treatments and wound healing, making them a well-established application of somatic cell technologies. Bioscaffolds and scaffold-free systems are essential tools in the somatic cell therapies market. Hence, such factors are fuelling the growth of this segment during the forecast period.
Which Region is Leading the Market?
For more insights on the market share of various regions Request Free Sample
North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The North American market is witnessing notable progress, fueled by groundbreaking research, development, and commercialization of novel therapies. This region is a frontrunner in the global cell therapy market, with substantial investments and strategic initiatives driving industry growth.
How do Technavio's company ranking index and market positioning come to your aid?
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Avantor Inc: The company offers cell therapy chemicals and reagents for biopharmaceutical, small molecule, fundamental and applied research, and environmental testing applications.
Technavio provides the ranking index for the top 20 companies along with insights on the market positioning of:
- Becton Dickinson and Co.
- Bio Techne Corp.
- Corning Inc.
- Danaher Corp.
- Fresenius Kabi AG
- FUJIFILM Irvine Scientific Inc.
- Korber Medipak Systems GmbH
- Lonza Group Ltd.
- Merck KGaA
- Miltenyi Biotec B.V. and Co. KG
- Revvity Inc.
- Sartorius AG
- STEMCELL Technologies Inc.
- TERUMO BCT, INC
- Thermo Fisher Scientific Inc.
Explore our company rankings and market positioning Request Free Sample
How can Technavio Assist you in Making Critical Decisions?
What is the Market Structure and Year-over-Year growth of the Market?
Market structure
|
Concentrated
|
YoY growth 2023-2024
|
17.2
|
Market Dynamic
Regulatory levels for cell-based therapies range from premarket approval-exempt therapies to investigational therapies. Genetic engineering has expanded the therapeutic benefits of cell therapy, with genetically reprogrammed pluripotent cells offering off-the-shelf solutions. Immunophenotypic profiles and infusions of hematopoietic stem cells, blood-forming stem cells, neural stem cells, and adult stem cells have shown clinical safety and efficacy in treating connective tissue diseases, blood disorders, lymphatic diseases, bone injuries, cartilage damage, and immune system disorders. Bioscaffolds and scaffold-free systems have further enhanced the potential of cell therapy, allowing for the growth and differentiation of various cell types, including skin stem cells, pancreatic islet cells, and lymphocytes, such as dendritic cells. Cell therapy holds immense promise for disease treatment, with ongoing research focusing on improving therapeutic benefits, clinical safety, and efficacy. The future of cell therapy lies in the continued exploration of new cell types, isolation techniques, and mechanisms of action. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
What are the Primary Factors Driving the Market Growth?
Increased investment in cell therapy is notably driving market growth. The market is witnessing a substantial influx of investments, fueling noteworthy advancements and growth in the sector. This trend is marked by substantial financial commitments from leading companies and organizations, aimed at enhancing cell therapy manufacturing capabilities and broadening therapeutic applications.
These investments will significantly contribute to the advancement of multicellular therapies, including those for cancer and immune diseases, by leveraging the potential of both autologous and allogeneic cells. This investment surge underscores the immense promise of cell therapy technologies in regenerative medicine and their capacity to revolutionize healthcare. Thus, such factors are driving the growth of the market during the forecast period.
What are the Significant Trends being Witnessed in the Market?
Mergers and acquisitions is the key trend in the market. The market has experienced a wave of mergers and acquisitions, signifying a strategic consolidation to strengthen technological capabilities and broaden market presence. Notable transactions in this industry underscore its agility and the strategic maneuvers of major players to fortify their positions. Thus, such trends will shape the growth of the market during the forecast period.
What are the Major Market Challenges?
High costs related to cell therapy technologies is the major challenge that affects the growth of the market. The market encounters substantial challenges due to the high costs involved in creating and distributing these innovative treatments. These expenses impede the rate of development and limit patient access, significantly hindering market expansion. One of the major contributors to these elevated costs is the intricacy of manufacturing procedures.
Developing cell therapies necessitates advanced equipment and rigorous quality control protocols to ensure patient safety and treatment efficacy. These procedures are typically labor-intensive and rely on advanced technologies, leading to increased production costs. Furthermore, cell therapies often involve personalized treatments designed for individual patients based on their unique immunophenotypic profiles. Hence, the above factors will impede the growth of the market during the forecast period.
Exclusive Customer Landscape
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Market Analyst Overview
Cell therapy technologies have revolutionized the field of regenerative medicine, offering innovative solutions for treating various diseases, particularly cancer and immune disorders. These therapies leverage the potential of multicellular systems, including mesenchymal stem cells, autologous cells, allogeneic cells, and unicellular therapies. Mesenchymal stem cells, derived from various tissues, play a crucial role in regenerative medicine. Isolation techniques have advanced to ensure the purity and viability of these cells. Mechanisms of action for these therapies include direct replacement of damaged tissue, paracrine effects, and immune modulation.
Market Scope
|
Report Coverage
|
Details
|
Page number
|
209
|
Base year
|
2023
|
Historic period
|
2018 - 2022 |
Forecast period
|
2024-2028
|
Growth momentum & CAGR
|
Accelerate at a CAGR of 19.7%
|
Market growth 2024-2028
|
USD 5.92 billion
|
Regional analysis
|
North America, Europe, Asia, and Rest of World (ROW)
|
Performing market contribution
|
North America at 39%
|
Key countries
|
US, China, Germany, UK, and Japan
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled
|
Avantor Inc., Becton Dickinson and Co., Bio Techne Corp., Corning Inc., Danaher Corp., Fresenius Kabi AG, FUJIFILM Irvine Scientific Inc., Korber Medipak Systems GmbH, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. and Co. KG, Revvity Inc., Sartorius AG, STEMCELL Technologies Inc., TERUMO BCT, INC, and Thermo Fisher Scientific Inc.
|
Market dynamics
|
Parent market analysis, market research and growth , market report, market forecast , market growth inducers and obstacles, fast-growing and slow-growing segment analysis, AI impact on market trends, COVID -19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period
|
Customization purview
|
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
|
Download PDF Sample
What are the Key Data Covered in this Market Research Report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
- Precise estimation of the size of the market and its contribution of the market in focus to the parent market
- Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market's competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the growth of market companies
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
- 5.1 Global Cell Therapy Technologies Market 2018 - 2022
- Historic Market Size - Data Table on Global Cell Therapy Technologies Market 2018 - 2022 ($ million)
- 5.2 Technology segment analysis 2018 - 2022
- Historic Market Size - Technology Segment 2018 - 2022 ($ million)
- 5.3 End-user segment analysis 2018 - 2022
- Historic Market Size - End-user Segment 2018 - 2022 ($ million)
- 5.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 5.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI in the Global Cell Therapy Technologies Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 7.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Technology
- 8.1 Market segments
- Chart on Technology - Market share 2023-2028 (%)
- Data Table on Technology - Market share 2023-2028 (%)
- 8.2 Comparison by Technology
- Chart on Comparison by Technology
- Data Table on Comparison by Technology
- 8.3 Somatic cell technologies - Market size and forecast 2023-2028
- Chart on Somatic cell technologies - Market size and forecast 2023-2028 ($ million)
- Data Table on Somatic cell technologies - Market size and forecast 2023-2028 ($ million)
- Chart on Somatic cell technologies - Year-over-year growth 2023-2028 (%)
- Data Table on Somatic cell technologies - Year-over-year growth 2023-2028 (%)
- 8.4 Gene modification techniques - Market size and forecast 2023-2028
- Chart on Gene modification techniques - Market size and forecast 2023-2028 ($ million)
- Data Table on Gene modification techniques - Market size and forecast 2023-2028 ($ million)
- Chart on Gene modification techniques - Year-over-year growth 2023-2028 (%)
- Data Table on Gene modification techniques - Year-over-year growth 2023-2028 (%)
- 8.5 Genome editing technologies - Market size and forecast 2023-2028
- Chart on Genome editing technologies - Market size and forecast 2023-2028 ($ million)
- Data Table on Genome editing technologies - Market size and forecast 2023-2028 ($ million)
- Chart on Genome editing technologies - Year-over-year growth 2023-2028 (%)
- Data Table on Genome editing technologies - Year-over-year growth 2023-2028 (%)
- 8.6 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
- 8.7 Market opportunity by Technology
- Market opportunity by Technology ($ million)
- Data Table on Market opportunity by Technology ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- Chart on End-user - Market share 2023-2028 (%)
- Data Table on End-user - Market share 2023-2028 (%)
- 9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 9.3 Biopharmaceuticals and biotechnology companies - Market size and forecast 2023-2028
- Chart on Biopharmaceuticals and biotechnology companies - Market size and forecast 2023-2028 ($ million)
- Data Table on Biopharmaceuticals and biotechnology companies - Market size and forecast 2023-2028 ($ million)
- Chart on Biopharmaceuticals and biotechnology companies - Year-over-year growth 2023-2028 (%)
- Data Table on Biopharmaceuticals and biotechnology companies - Year-over-year growth 2023-2028 (%)
- 9.4 CROs and CMOs - Market size and forecast 2023-2028
- Chart on CROs and CMOs - Market size and forecast 2023-2028 ($ million)
- Data Table on CROs and CMOs - Market size and forecast 2023-2028 ($ million)
- Chart on CROs and CMOs - Year-over-year growth 2023-2028 (%)
- Data Table on CROs and CMOs - Year-over-year growth 2023-2028 (%)
- 9.5 Research institute and cell banks - Market size and forecast 2023-2028
- Chart on Research institute and cell banks - Market size and forecast 2023-2028 ($ million)
- Data Table on Research institute and cell banks - Market size and forecast 2023-2028 ($ million)
- Chart on Research institute and cell banks - Year-over-year growth 2023-2028 (%)
- Data Table on Research institute and cell banks - Year-over-year growth 2023-2028 (%)
- 9.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)
- 11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 11.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 11.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 11.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 11.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 11.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 11.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 11.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 11.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 11.12 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
- 11.13 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 11.14 South Korea - Market size and forecast 2023-2028
- Chart on South Korea - Market size and forecast 2023-2028 ($ million)
- Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
- Chart on South Korea - Year-over-year growth 2023-2028 (%)
- Data Table on South Korea - Year-over-year growth 2023-2028 (%)
- 11.15 Italy - Market size and forecast 2023-2028
- Chart on Italy - Market size and forecast 2023-2028 ($ million)
- Data Table on Italy - Market size and forecast 2023-2028 ($ million)
- Chart on Italy - Year-over-year growth 2023-2028 (%)
- Data Table on Italy - Year-over-year growth 2023-2028 (%)
- 11.16 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
- 11.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 12.4 Market opportunities/restraints
13 Competitive Landscape
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14.2 Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 Avantor Inc.
- Avantor Inc. - Overview
- Avantor Inc. - Business segments
- Avantor Inc. - Key news
- Avantor Inc. - Key offerings
- Avantor Inc. - Segment focus
- SWOT
- 14.5 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
- 14.6 Bio Techne Corp.
- Bio Techne Corp. - Overview
- Bio Techne Corp. - Business segments
- Bio Techne Corp. - Key news
- Bio Techne Corp. - Key offerings
- Bio Techne Corp. - Segment focus
- SWOT
- 14.7 Corning Inc.
- Corning Inc. - Overview
- Corning Inc. - Business segments
- Corning Inc. - Key news
- Corning Inc. - Key offerings
- Corning Inc. - Segment focus
- SWOT
- 14.8 Danaher Corp.
- Danaher Corp. - Overview
- Danaher Corp. - Business segments
- Danaher Corp. - Key news
- Danaher Corp. - Key offerings
- Danaher Corp. - Segment focus
- SWOT
- 14.9 Fresenius Kabi AG
- Fresenius Kabi AG - Overview
- Fresenius Kabi AG - Product / Service
- Fresenius Kabi AG - Key offerings
- SWOT
- 14.10 FUJIFILM Irvine Scientific Inc.
- FUJIFILM Irvine Scientific Inc. - Overview
- FUJIFILM Irvine Scientific Inc. - Product / Service
- FUJIFILM Irvine Scientific Inc. - Key offerings
- SWOT
- 14.11 Lonza Group Ltd.
- Lonza Group Ltd. - Overview
- Lonza Group Ltd. - Business segments
- Lonza Group Ltd. - Key news
- Lonza Group Ltd. - Key offerings
- Lonza Group Ltd. - Segment focus
- SWOT
- 14.12 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
- 14.13 Miltenyi Biotec B.V. and Co. KG
- Miltenyi Biotec B.V. and Co. KG - Overview
- Miltenyi Biotec B.V. and Co. KG - Product / Service
- Miltenyi Biotec B.V. and Co. KG - Key news
- Miltenyi Biotec B.V. and Co. KG - Key offerings
- SWOT
- 14.14 Revvity Inc.
- Revvity Inc. - Overview
- Revvity Inc. - Business segments
- Revvity Inc. - Key offerings
- Revvity Inc. - Segment focus
- SWOT
- 14.15 Sartorius AG
- Sartorius AG - Overview
- Sartorius AG - Business segments
- Sartorius AG - Key news
- Sartorius AG - Key offerings
- Sartorius AG - Segment focus
- SWOT
- 14.16 STEMCELL Technologies Inc.
- STEMCELL Technologies Inc. - Overview
- STEMCELL Technologies Inc. - Product / Service
- STEMCELL Technologies Inc. - Key offerings
- SWOT
- 14.17 TERUMO BCT, INC
- TERUMO BCT, INC - Overview
- TERUMO BCT, INC - Product / Service
- TERUMO BCT, INC - Key offerings
- SWOT
- 14.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
15 Appendix
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations